• Approval in 2 Weeks via FDA's New Oncology Drugs Review

    24 days ago - By Medscape

    Approval of a new indication took only 2 weeks with the FDA's new program for reviewing oncology drugs. It involved expanded use of the lymphoma drug brentuximab vedotin.
    FDA Approvals
    Read more ...

     

  • FDA Approves First-Line Adcetris for Peripheral T-Cell Lymphoma

    24 days ago - By MedPageToday

    Added to chemotherapy, drug delayed disease progression by over 2 years
    Read more ...

     

  • New first-line treatment for peripheral T-cell lymphoma approved by FDA

    24 days ago - By News Medical

    The U.S. Food and Drug Administration today expanded the approved use of Adcetris injection in combination with chemotherapy for adult patients with certain types of peripheral T-cell lymphoma.
    Read more ...